Introduction: Implant infection is serious; prevention is mandatory, and requires assessment. The present study assessed the incidence of deep surgical-site infection (SSI) at 1 year following total knee arthroplasty (TKA) and adherence to skin preparation, antibiotic prophylaxis, screening and prevention in case of methicillin-resistant S. aureus (MRSA). Hypothesis: Adherence to prevention measures reduces infection risk secondary to TKA. Material and methods: A prospective study of the incidence of SSI following primary TKA was run from December 1st 2005 to December 31st 2006 in a continuous series of 364 operations in 359 patients, excluding cases of septic or aseptic revision. Each implant was followed up for 12 months. Adherence to practice was assessed by independent observers. Antibiotic prophylaxis was assessed; skin preparation was scored (out of 10); MRSA was systematically screened for, and preventive measures were assessed in positive cases. Median follow-up was 12 months. Patients with less than 11 months' FU were contacted by telephone. Median age was 72 years (range, 45-92 years). Eighty-seven percent of patients had ASA scores of 2; 14% were diabetic, and 42% obese. Mean surgery time was 70 min (range, 30-164 min). Among the implants, 81.5% were cemented. Eighty-six percent of operations had NNIS scores of 0. Infection risk linked to theater environment and teams was under control. Results: Fourteen patients were lost to follow-up and excluded from analysis. The incidence of infection was 1.4% (n = 5/350) (95% CI [0.41-3.22]). Three of the infections were early (≤ 1 month), and two were polymicrobial. Antibiotic prophylaxis was implemented correctly in 99% of cases, with skin preparation scores of 8.75 in 61% of cases and of 10 in 39%. Among the pattients, 2.5% were MRSA-positive, none of whom developed infection. Infection prevention measures were applied in only half of the MRSA-positive cases. No MRSA-positive patients developed SSI.
Introduction
Implant infection is especially serious in terms of morbidity and cost [1] . Infection risk prevention is codified and subject to good practice recommendations [2] . Assessment should be routine [3] , as part of general practice quality control.
The present study measured the incidence of deep surgical-site infection (SSI) secondary to total knee replacement (TKA), and assessed adherence to infection risk prevention measures: skin preparation, antibiotic prophylaxis, and screening and management for methicillin-resistant Staphylococcus aureus (MRSA), for which corrective action was advised as appropriate.
The hypothesis was that adherence to infection risk prevention measures would reduce the incidence of SSI following TKA.
Material and methods

Deep surgical site infection incidence study
A prospective study of the incidence of SSI following TKA was run from December 1st 2005 to December 31st 2006 in a continuous series of 364 operations performed in the Polyclinique du Parc, Saint Saulve (France). Following inclusion over this 13-month period, a 12-month follow-up was conducted in all cases.
The inclusion criterion was primary TKA, with or without prior history of surgery. Cases of aseptic (loosening, wear) and septic revision were excluded. SSI was defined following Horan et al. [4] as applied in France [5, 6] (Table 1) . Bac- Table 1 Deep infection after knee arthroplasty. Clinical and bacteriological definitions. [5] Infection occurring within 30 days following surgery or within 1 year in case of implant, prosthesis or prosthetic material, involving tissue, organs or spaces at or below the covering aponeurosis or still open or manipulated during surgery, and diagnosed by: Case 1: purulent effusion from a drain below the aponeurosis or in the organ, site or space Case 2: spontaneous dehiscence of incision or opening by the surgeon with at least one of the following signs: fever > 38
• C, localized pain or sensitivity on palpation And micro-organism isolated by culture, obtained aseptically by organ harvesting or site or space sampling OR without culture (excluding negative culture without antibiotherapy) Case 3: abscess or other sign of infection on revision surgery, histopathology, imaging or interventional radiology [8] > 3 peroperative samples (no antibiotics for 2 weeks) ≥ 3 samples positive for the same bacillus ≤ 2 samples positive for the same bacillus: -Virulent bacillus (S. aureus, P. aeruginosa, etc.) -Discussion between surgeon and infectologist according to clinical aspect in case of skin flora (CNS, Propionibacterium. . .)
teriological data were derived from peroperative samples taken under strict asepsis (direct puncture, peroperative tissue and/or material samples) [7, 8] . Superficial swabs (fistula opening) were excluded, thereby excluding superficial infections from the final analysis. SSI was diagnosed by consensus after discussion between surgeon, infectologist and study coordinator.
Surgical protocol
Operations were performed in 4 surgery rooms equipped with laminar flow. Terminal filtration was by High Efficiency Particulate Air (HEPA) filter, filtering out 99.9% of > 0.3( particles. Annual air particle control confirmed that the surgical rooms met quality requirements (ISO5 NFX 44-101 air cleanliness norm) [9] . The surgical team wore sterile robes, masks and double gloves. Hand disinfection was by rubbing with a hydroalcoholic solution. Theater maintenance comprised floor bio-cleansing and flat-surface spraying with detergentdisinfectant at the start of the surgical program and between operations. Furnishings were damp-dusted at the end of the program.
Good practice assessment
Adherence was assessed against local recommendations (Table 2) .
Antibiotic prophylaxis: injection molecule, duration, dose and time were recorded by the anesthetist [10] . The study team performed a final assessment according to the study criteria [11] . Skin preparation: the study team assessed implementation of a protocol based on French national recommendations [2] , using the ward and theater liaison reports. Skin preparation was scored out of 10 [12] : five points for skin preparation in the ward (2.5 for shower, 2.5 for depilation) and five points for skin preparation in the surgery room (1.25 for cleaning, 2.5 for antisepsis and contact time, and 1.25 for the antiseptic employed).
Pre-operative MRSA screening: the patient's surgeon systematically prescribed a nasal swab, performed by a biologist of the patient's choosing, plus another for any cutaneous lesions (chronic or not). MRSA was detected by culture (MRSATM, Biomérieux, France). Results were recorded in the patient's treatment or consultation file. In case of positive findings, the study team assessed preventive action (treatment file, prescription form, anesthesiology file).
Stomatologic examination was not systematic.
Cohort characteristics
Five surgeons performed 364 TKAs in 359 patients (73% female) during the inclusion period. Median patient age was 72 years (range, 45-92 years) ( Table 3) . Forty-two percent of patients (n = 154/364) were obese (body-mass index [BMI] ≥ 30). Eighty-seven percent (n = 312/364) had American Society of Anesthesiologists (ASA) scores of 2 or 3 (mild or severe systemic disease, respectively). Eight patients (2%) presented with pre-operative systemic infection (seven urinary infections and one streptococcal erysipelas). Respectively 4.5% (16/364), 3.6% (13/364) and 1% (4/364) presented with respiratory insufficiency, smoking habit or immunodepression (immunosuppressors, long-course corticotherapy, recent high-dose corticotherapy, neutropenia less than 500 per millimetre cube, chemoradiotherapy). Fourteen percent (50/364) were diabetic. Among them, 22.2% (81/364) had a history of knee surgery (meniscectomy, osteotomy, arthroscopy). The postoperative blood-transfusion rate was 12% (44/364). TKA was indicated for primary arthritis without history of infection (no rheumatoid polyarthritis).
An anteromedial approach was used in 76% (276/364) of cases. Associated surgery (5%) concerned the patellar retinaculum or anterior tibial tuberosity transposition. TKAs were cemented in 81.5% (297/364) of cases, and systematically contained antibiotics (gentamicin, or erythromycin-colistin). The National Nosocomial Infection Surveillance System (NNIS) score was 0 in 86% (311/364) of cases. Drainage was systematically employed for between 48 and 72 hours (max.).
Data collection
A methodology guide was provided to all surgeons, with information to the surgery teams and ward staff. One form was filled in per patient and per implant, comprising patient data (gender, age, known SSI risk factors, and ASA score [13] ), operative data (date, duration, laminar flow, approach and associated surgery, cementing, NNIS score [14] , and antibiotic prophylaxis) and postoperative data (wound complications, non related with the knee infection which were not located in the knee, revision without infection, or SSI). Patients were considered obese when the BMI exceeded 30 on the international scale [15] . The form also contained all of the informations regarding good practice.
After discharge, patients were followed up at a rhythm set by the surgeon. The survey form was distributed to the surgery office, so as to ensure continuity. The OSOFT6TM software package, employed in the institution for medical files in general (admission, clinics, prescription), was used to gather information in postoperative clinics and to list those patients with less than 12 months' FU, who were then contacted by telephone (at home and/or via their GP, or at their residential institution: retirement home, postoperative care or long-stay institution). Patients who did not come to follow-up clinics and could not be contacted by telephone within 12 months post-surgery were considered lost to follow-up. The list of patients included in the study was crossreferenced with the pharmacy records for antibiotic prescriptions over the same period and with the institution's medical information system data for implant infection.
Infected patients were managed by the institution's infectologist, whose records confirmed and specified the SSI.
Survey management
The survey was managed by the operational hygiene team. Pre-, per-and postoperative information was recorded by the theater hygiene nurse and validated by the hygiene physician, who cross-referenced the survey forms, the admission and consultation files and the information from the other above-mentioned data-bases.
Statistical analysis
The data were entered into EPI604Fr software for Bartlett 2 and Wilcoxon analysis.
Results
Deep surgical site infection incidence and description
At least 12 months' follow-up was achieved in 78.5% (286/364) of patients. Telephone contact, for the 78 patients having not more than 11 months' follow-up, was informative (response or death) in 82% of cases (64/78). No deaths were linked to SSI. For 14 of these 78 patients, no information was available (Fig. 1) , and they were excluded from SSI incidence analysis. The denominator in calculating SSI incidence combined the 286 patients with at least 12 months' FU, the 54 telephone respondents and the 10 cases of death during the study period: i.e., 350 patients in all.
Five SSIs were detected (Table 4) , for an incidence of 1.42% (5/350) (95% CI [0.41-3.22]). Four of these five patients were obese (including one morbid obesity). One had history of ipsilateral limb surgery. One patient had an ASA score of 1, 2 of 2 and 2 of 3. There were no cases of previous peri-and/or intra-articular infiltration, corticosteroids or hyaluronic acid injection. Median surgery time was 70 min • percentile. Skin preparation score was 10/10 in three of the five cases. SSIs were evenly distributed between surgeons. Three cases were of early (1st month) infection. Four of the six peroperative samples were Gram-positive and MRSA was isolated in one deep peroperative sample.
Infection risk prevention assessment
Surgical antibiotic prophylaxis was properly performed in 99% of cases. Cefazolin and vancomycin were employed in respectively 96% and 4% of cases (Table 3) . Ninety-nine percent (361/364) of prescriptions were for 24 hours, two for 48 hours and in one case the duration was not specified in the anesthesiology records.
Skin preparation score was 8.75 in 61% of cases and 10 in 39%. The most frequent error was failure to perform a second application or to respect the time of action of the antiseptic. Seventy-three percent of patients had had oral instructions regarding preoperative showering on the eve of surgery or during the anesthesiology clinics. Chlorhexidine-based substances (chlorhexidine foam solution or chlorhexidine in alcohol for local application) were used in 96% of cases and povidone iodine in 4%.
Ninety-nine percent of patients underwent MRSA screening, at a median 13 days before surgery (range, 0-90 days). In nine patients (2.5%), MRSA was found. Seven percent (29/364) presented one or more MRSA risk factors (recent history of surgery, cutaneous lesion, referral from high-risk wards, and notably long-term rehabilitation units) with significantly elevated risk of infection (P < 10 -4 ). In case of 
Impact of prevention measures
None of the classic risk factors (obesity, diabetes, history of ipsilateral limb surgery, ASA score or NNIS score) could thus be analyzed. The impact on SSI of failure to implement prevention, in the form of incomplete skin preparation, was not significant: relative risk, 0.43 (95% CI [0.07 < RR < 2.55]). No patients with SSI had been MRSA positive for MRSA before surgery. For half of the MRSA-positive patients, prevention measures had failed to be implemented (ignorance of guidelines and/or negligence), without SSI ensuing. Failure to apply antibiotic prophylaxis recommendations was rare in the present study, and without impact.
Discussion
The present study falls under care-facility obligations with regard to implementing surveillance and infection risk prevention strategies, notably in surgery. We are required to identify surveillance indicators derived from a recognized methodology, often as part of the French ''INCISO'' SSI surveillance program. The other aspect concerns assessment of the implementation of good practice recommendations.
Our center, with a high volume of TKA, sought to set up a quality assurance program meeting the described requirements. The present assessment of working practice illustrates this.
Mean surgery time was shorter than reported elsewhere (Table 5 ).
Critical analysis of deep surgical site infection incidence, and study limitations SSI incidence in the present series was low, and in the lower range (0.39% to 4.29%) of previous reports that had, however, longer follow-up (over 7 years as a mean for the relevant studies as a whole [16] [17] [18] [19] [20] [21] [22] , compared to the present median of 12 months). The difficulties inherent to this kind of survey, however, are to be borne in mind. The percentage of patients with less than 12 months' FU in the present study was considerable, and this represents an important limitation given the interval stipulated in the definition of deep SSI [5] : 30 days postoperatively, or within 1 year in case of prosthetic implantation. The percentage lost to follow-up was finally quite low, but the quality of the information gleaned from telephone contact is obviously open to discussion. The reason given for not attending follow-up clinics was the absence of any complication (mechanical and/or infectious). Despite this bias, these patients were included in calculating the denominator. Non-respondents were considered lost to follow-up, and excluded from analysis.
It can obviously not be ruled out that infected patients whom we failed to identify may have contacted some other surgeon or consulted in a specialized osteoarticular infection center. Even so, we would agree with Lecuire et al. [19] that infected patients tend to remain loyal to their surgeon.
The rarity of infection accounts for the wide confidence interval, which hinders comparison with other centers' reports. Our present rate of incidence is, however, very likely an underestimation.
Apart from such technical epidemiological problems, confirming SSI is by no means straightforward in certain situations, despite apparently limpid definitions. This is indeed the main problem faced in such a survey. For example, case no.2 was defined as SSI by consensual clinical analysis despite non-acceptable bacteriological findings (superficial swab sampling) and a negative peroperative sample! ''Managing an infected prosthesis means entering a domain of diagnostic, bacteriologic and therapeutic doubt'' [23] .
This raises the issue of the role of SSI surveillance as a significant element in the fight against nosocomial infection, and indeed of the regulation-bound nature of SSI surveillance. Historically, the strategy initiated in France in the 1990s in the form of national and regional networks enabled the scale of the issue to be appreciated, the main risk factors to be identified, the national ISO-RAISIN data-base to be constructed and the SSI rate to be shown to decrease when prevention was coupled to epidemiological surveillance. As Hajjar states in his editorial [24] , SSI rates are not simple equations! They are difficult to interpret, even at local level, due to methodological difficulties. Comparing SSI rates is made all the more difficult by the number of variability factors (indicator sensitivity/specificity, quality of care, work organization and staff qualification). To quote Hajjar again, ''It is not a matter of questioning the legitimacy of information provided to users, but of insisting on the virtual absence of scientific certainty as to the improvement of care quality with the publication of infection rates.'' Moreover, the technical demands of producing the indicator (study-team work-load, difficult data collection, low-grade information systems, unequal commitment of the various contributors, incomplete exhaustiveness, etc.) are onerous.
Finally, implementing preventive measures of proven efficacy does avoid most cases of SSI. It therefore seems more beneficial (for the patient) and certainly less costly (for the care facility) to focus on prevention and the assessment of the quality of implementation, even if this means reporting SSI rates at longer intervals.
Assessment of practice
The present study was not a self-assessment, but an audit performed by independent survey team (hygiene physician and nurse).
Surgical antibiotic prophylaxis was assessed on several occasions in our institution, stimulating orthopedic physicians and anesthetists to implement the French Society of Anesthesiology and Intensive Care (SFAR) recommendations scrupulously [11] . The importance of respecting national recommendations from the point of view of litigation (especially in orthopedic surgery) largely explains the good present results.
Skin preparation followed a written protocol based on national recommendations [2] made widely available to medical and paramedical staff, with numerous in-house information sessions over a number of years. Even so, it was defective in one third of cases, although without impact in terms of infection.
MRSA-positivity is rare and not systematically taken into account, without apparent impact on infection risk. A recent, statistically robust, study [25] reported no significant difference in MRSA SSI rates between non-screened (0.99%) and screened (1.14%) cohorts (decontamination and antibiotic prophylaxis adaptation). Kalmeijer et al. studied the inefficacy of nasal (mupirocin) decontamination in MRSA [26] . Two years previously, Kalmeijer et al. showed that a high rate of nasal colonization was a major SSI risk factor [27] . Perl et al. [28] reported that nasal mupirocin prevented such infection. The debate is thus not yet closed, and further study is required [29] . In our institution, systematic screening ahead of TKA has been discontinued.
The ''ecological'' environment of surgery in terms of air and surfaces and their treatment is under control. The change in habits involved in moving from surgical hand-washing with antiseptic soap (2005) to surgical rubbing with a hydro-alcoholic solution (2006) would not seem to have led to an increase in SSI rates (data from targeted SSI surveillance in our orthopedic, visceral, urologic and neurologic surgery departments under the SURVISO network piloted by the North Paris nosocomial infection coordination center (CCLIN): overall SSI rates were 2.72% in 2006, 0.90% in 2007 and 1.6% in 2008).
Conclusion
The initial hypothesis could not be confirmed, because of the limitations of epidemiological interpretation due to the small number of infected patients and the problems raised by postoperative surveillance. Defective implementation of recommendations, notably regarding skin preparation, and MRSA colonization did not seem to exacerbate risk. However, the weak points highlighted by the assessment are perhaps relatively unimportant in as much as the time of infection risk exposure (duration of surgery) is short, surgical antibiotic prophylaxis is correctly implemented, skin preparation conforms to generally accepted principles and MRSA colonization seems not to play a major role in the present findings.
Our priority was to assess implementation of inherent surgical infection risk prevention measures with respect to forensic expertise in case of implant infection. Forensic expertise analyzes the circumstances of infection onset, severity, prevention measures undertaken (protocols, traceability, assessments, epidemiological surveillance, proof of an institutional infection risk prevention strategy) and the quality of infection management. It is, however, sometimes difficult to convince users that ''zero risk'' is but a pious hope. This is all the harder to accept as the limits of prevention would seem to have been reached and the notion of unpredictable treatment outcome is going to be with us for a long time to come.
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